Jesús
San Miguel Izquierdo
Consultor Investigador
Hospital de Sant Pau i Santa Tecla
Tarragona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de Sant Pau i Santa Tecla (2)
2012
-
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease
Haematologica, Vol. 97, Núm. 4, pp. 616-621
-
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: A randomized phase 3 PETHEMA/GEM study
Blood, Vol. 120, Núm. 8, pp. 1589-1596